logo
Select company
Select metric
$ 71.35MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
10
Sector
14
Industry
20
History
33
$ 13.75Close
$ 6.5 - $ 17.02 52-Week Range
Ticker Information

Ticker

SRZN

Company Name

SURROZEN INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SURROZEN INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SRZN - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 71.35M
3/31/2025$ 92.56M
12/31/2024$ 16.18M
9/30/2024$ 16.23M
6/30/2024$ 16.21M
3/31/2024$ 315K
12/31/2023$ 276K
9/30/2023$ -2.33M
6/30/2023$ -2.33M
3/31/2023$ -2.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SURROZEN INC's latest trailing twelve months (TTM) CF - Equity stands at $ 94.5M.
  • Over the past 5 years, SURROZEN INC's average CF - Equity has been $ 41.97M.
  • The median CF - Equity for SURROZEN INC during this period was $ 16.2M
  • SURROZEN INC reached its highest CF - Equity over the past 5 years at $ 124.63M.
  • The lowest CF - Equity recorded by SURROZEN INC in the same timeframe $ -2.52M

SURROZEN INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
CRVO : CERVOMED INC $ -13.34KCUE : CUE BIOPHARMA INC $ 29.69MTCRX : TSCAN THERAPEUTICS INC $ 1.8MFATE : FATE THERAPEUTICS INC $ 0HYFT : MINDWALK HOLDINGS CORP $ 8.47MCBUS : CIBUS INC $ 0VRCA : VERRICA PHARMACEUTICALS INC $ 39.64MOVID : OVID THERAPEUTICS INC $ 51KIRD : OPUS GENETICS INC $ 22.07MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 1.3M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

SRZN - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -2.52M

Minimum

Mar 31, 2023

$ 124.63M

Maximum

Dec 31, 2021

$ 41.97M

Average

$ 16.2M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 113.43K with a standard deviation of $ 17.63M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 113.43K
median$ 0
std$ 17.63M